The solute carrier (SLC) monocarboxylate transporter1 (MCT1; SLC16A1)represents a promising target for the treatment of cancer; however,the MCT1 modulator landscape is underexplored with only roughly 100reported compounds. The gene discussed is SLC16A1; the disease is cancer.